Company Profile
Updated: 23-NOV-09Myogen Inc.
Private Subsidiary, Headquarters Location
7577 W 103rd Ave., Ste. 212, Westminster, CO 80021-5426, United States
(303)410-6666, (303)410-6667 fax, http://www.myogen.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Biopharmaceuticals for the treatment of heart failure and related cardiovascular conditions.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
United States : SEC Charges Former Employees Of Global Firms In Serial Insider Trading Scheme.
TendersInfo; 12/18/2009; 798 words; ...illegally tipped material, nonpublic information that Lazard clients were in negotiations to acquire webMethods, Inc. and Myogen, Inc. Zaman tipped the information to Vaghar and Khoury through in-person meetings or by writing trading instructions...
SEC Charges Former Employees of Global Firms in Serial Insider Trading Scheme.
M2 Presswire; 12/17/2009; 993 words; ...clients were in negotiations to acquire webMethods, Inc. and Myogen, Inc. Zaman tipped the information to Vaghar and Khoury through...Investigation, and the Chicago Board Options Exchange, Inc. for their cooperation and assistance in connection...
SEC charges former employees of Lazard and TPG Capital in serial insider trading scheme.
CPI Financial; 12/17/2009; 842 words; ...illegally tipped material, nonpublic information that Lazard clients were in negotiations to acquire webMethods, Inc. and Myogen, Inc. Zaman tipped the information to Vaghar and Khoury through in-person meetings or by writing trading instructions...
Phase III Darusentan Failure Puts Gilead's CV Push on Hot Seat.
BIOWORLD Today; 12/16/2009; 1141 words; ...5 billion Gilead spent to acquire Myogen Inc. Darusentan was the headline asset...article&forceid=41031).) Myogen also gave Gilead the marketed pulmonary...billion acquisition of CV Therapeutics Inc., which included the marketed chronic...
SEC CHARGES FORMER EMPLOYEES OF GLOBAL FIRMS IN SERIAL INSIDER TRADING SCHEME.
States News Service; 12/16/2009; 1125 words; ...clients were in negotiations to acquire webMethods, Inc. and Myogen, Inc. Zaman tipped the information to Vaghar and Khoury through...Investigation, and the Chicago Board Options Exchange, Inc. for their cooperation and assistance in connection...
Recent News Articles
- Bioheart, Inc. Expands Clinical Trials of Adult Myogenic Stem Cell Treatment for Heart Attack and Advanced Heart Failure Patients.
PR Newswire - November 16, 2006 - Gilead Sciences to Acquire Myogen, Inc. for $2.5 Billion and Genzyme Receives European Approval for Synvisc(R).
M2 Presswire - October 03, 2006 - Bellwetherreport.com is Tracking Myogen Inc.
M2 Presswire - October 02, 2006 - Gilead Sciences to Acquire Myogen, Inc. for $2.5 Billion.
Business Wire - October 02, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning